A recent study has demonstrated the safety and efficacy of bulevirtide (BLV) monotherapy for 48 weeks in difficult-to-treat patients with hepatitis delta virus (HDV)-related compensated cirrhosis and clinically significant portal hypertension (CSPH).
Using collateral flow findings, as seen on computed tomographic (CT) angiography, may widen the population who can undergo late endovascular treatment (EVT) for acute ischaemic stroke (AIS), according to findings of the MR CLEAN-LATE trial.
Patients on antifibrotics experience chest wall dehiscence earlier than those who did not receive antifibrotic treatment following lung transplantation, reveals a recent study, noting that this factor does not significantly influence survival.
Breast cancer patients with a more trustful bond with their physicians appear to be more open to taking adjuvant endocrine therapy (AET) and show lower concerns regarding the treatment, a recent study has found.
In the treatment of patients with multivessel coronary artery disease, percutaneous coronary intervention (PCI) with everolimus-eluting stents appears to yield similar outcomes in terms of the incidence of major adverse cardiac events, the composite safety endpoint, and all-cause mortality, according to the results of the BEST trial.
The use of alprazolam leads to rapid termination of seizures in patients with focal and/or generalized epilepsy treated in an inpatient setting, according to the results of the phase II study ENGAGE-E-001.
Although the incidence of myocarditis or pericarditis following mRNA COVID-19 vaccination is low, a two- to threefold higher likelihood is seen among individuals who received mRNA-1273 compared to BNT162b2 vaccine, reveals a study.